By comparing LGALS3 and LGALS3BP expression between the deceased and living GBM cases, we found that the deceased group had significantly elevated LGALS3 and LGALS3BP expression (P = 0.005 and P = 0.006, respectively) (Figure 3A,B). The gene discussed is LGALS3; the disease is glioblastoma.